Rheumatoid Factor Positive Plasma

• Description:

  Rheumatoid Factor Human Plasma_x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_

  Catalog number:	S2010001G
  Lot number:	Batch dependent
  Expiration date:	Batch depdendent
  Titer:	‰¥ 250 IU/mL
  Package Size:	Bulk (1 mL to 10 L)
  Appearance:	Slightly turbid
  Species:	Human
  Matrix:	Human plasma
  Storage:	-20°C. Avoid repeated freeze-thaw.
  Other names:	RF, rheumatoid arthritis factor, rheumatoid arthritis antibody
  Keywords:	Rheumatoid Factor, RF, rheumatoid arthritis factor, rheumatoid arthritis antibody, RF positive plasma, RF positive control, Rheumatoid Factor Positive Control

  _x000D_ References_x000D_ _x000D_

  _x000D_
  • Hollander, J. L. (1968). Rheumatoid Arthritis, Rheumatoid Factor, and Gamma G Globulin Fragments. Annals of Internal Medicine, 68(5), 1195.
  _x000D_
  • Pappas, D. A., and Bathon, J. M. (2009). Treatment of Rheumatoid Arthritis: Tumor Necrosis Factor Inhibitors. Rheumatoid Arthritis, 337€“349.
  _x000D_
  • Shingu, M., Ezaki, I., and Nobunaga, M. (1988). Complement-activating properties of immune complexes are suppressed by IgM rheumatoid factor and enhanced by IgG rheumatoid factor. Rheumatology International, 8(3), 95€“100.
  _x000D_
  • Vaughan, J. H. (1993). Pathogenetic concepts and origins of rheumatoid factor in rheumatoid arthritis. Arthritis and Rheumatism, 36(1), 1€“6.
  _x000D_
  • Xing Q, Fu L, Yu Z, Zhou X. Efficacy and Safety of Integrated Traditional Chinese Medicine and Western Medicine on the Treatment of Rheumatoid Arthritis: A Meta-Analysis. Evid Based Complement Alternat Med. 2020 Apr 2;2020:4348709.
  _x000D_
  • Raine C, Austin K, Giles I. Mechanisms determining the amelioration of rheumatoid arthritis in pregnancy: A systematic review. Semin Arthritis Rheum. 2020 Mar 19. pii: S0049-0172(20)30079-2.
  _x000D_
  • Toussirot E. The Interrelations between Biological and Targeted Synthetic Agents Used in Inflammatory Joint Diseases, and Obesity or Body Composition. Metabolites. 2020 Mar 13;10(3). pii: E107.
  _x000D_
  • Ishikawa Y, Terao C. The Impact of Cigarette Smoking on Risk of Rheumatoid Arthritis: A Narrative Review. Cells. 2020 Feb 19;9(2). pii: E475.
  _x000D_
  • Lin YJ, Anzaghe M, Schülke S. Update on the Pathomechanism, Diagnosis, and Treatment Options for Rheumatoid Arthritis. Cells. 2020 Apr 3;9(4). pii: E880.
  _x000D_
  • Capone A, Volpe E. Transcriptional Regulators of T Helper 17 Cell Differentiation in Health and Autoimmune Diseases. Front Immunol. 2020 Mar 12;11:348.
  _x000D_

  _x000D_  _x000D_ _x000D_ Related Products to Rheumatoid Factor Human Plasma: RF_x000D_ _x000D_ _x000D_  

• Short Description:

  Catalog #: S2010001G (Bulk)_x000D_ Rheumatoid Factor Positive Plasma consists of defibrinated human plasma positive for Rheumatoid Factor (‰¥250 IU/mL). This product is readily available in volumes ranging from a few mL to tens of Liters. Titer is assigned with the RF Latex method. All units have tested negative for infectious agents. This product can be used as molecular tool for various in vitro research and biochemical applications. Custom bulk orders of this product are available upon request._x000D_ _x000D_ Live Enquiry about this product via Text/SMS: 1-858-900-3210_x000D_ _x000D_  

• Weight:

  48

• Length:

  8

• Width:

  7

• Height :

  6